Pharmaceuticals
Company Overview of Xi'an Bohua Pharmaceutical Co., Ltd.
Company Overview
Xi'an Bohua Pharmaceutical Co., Ltd. engages in the development of pharmaceutical products. The company manufactures anti-microbial infection treatment for poultry, ornidazole. The company's products include alprazolam, alprazolam tablet, aspirin, aspirin enteric-coated tablets, aspirin tablet, analgin, aminophylline tablets, and aminopyrine. The company is based in Xian, China.
No. 156
Gongyuan Beilu
Xian, 714203
China
Founded in 1998
Phone:
86 29 251 8947
Key Executives for Xi'an Bohua Pharmaceutical Co., Ltd.
Xi'an Bohua Pharmaceutical Co., Ltd. does not have any Key Executives recorded.
Similar Private Companies By Industry
Company Name | Region |
Zhejiang Ruibang Pharmaceutical Co., Ltd. | Asia |
Abmart Inc. | Asia |
Aleph Biological Co., Ltd. | Asia |
Allist Pharmaceuticals, Inc. | Asia |
Alpha Pharmaceutical Co.,Ltd. Jiangsu Province | Asia |
Recent Private Companies Transactions
Type Date |
Target | |
No transactions available in the past 12 months. |

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
Company Name | Geographic Region |
Lawyers Committee for Civil Rights Under Law | United States |
The Advertising Council, Inc. | United States |
Tax Management Inc | United States |
John F. Kennedy Center For The Performing Arts | United States |
NYC2012, Inc. | United States |
Sponsored Financial Commentaries
Sponsored Links
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Xian Bohua Pharmaceutical Co., Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.